Missouri hospitalist, issue 48 (2013 July-September)

 

Complete issue and individual articles available.

Contents

  • Hospitalist Update
    • Monitoring and Metabolic Risks with Second Generation Antipsychotics / Rebecca Reiss
  • Diagnostic Dilemma
    • Diagnostic Dilemma / Sudharshan Balla
  • Ask a Specialist
    • Ask a Pathologist / Emily Coberly, Jonathan Shirshekan, and Eric Johannesen
  • ID Corner
    • Endocarditis / William Salzer
  • Conference Calendar
    • Missouri Hospitalist Calendar

Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.

Recent Submissions

  • Missouri hospitalist, issue 48 (2013 July-September) 

    (University of Missouri. Department of Medicine. Division of Hospital Medicine, 2013-07)

  • Conference Calendar (2013-07) 

    (University of Missouri, Department of Medicine, Division of Hospital Medicine, 2013-07)
    Conference Calendar.

  • Endocarditis 

    Salzer, William (University of Missouri. Department of Medicine. Division of Hospital Medicine, 2013-07)
    A recent basic clinical review of Infective Endocarditis in NEJM-Clinical practice.

  • Ask a pathologist 

    Coberly, Emily; Shirshekan, Jonathan; Johannesen, Eric (University of Missouri, Department of Medicine, Division of Hospital Medicine, 2013-07)
    QUESTION: I have heard about the recent increase in Paragonimus kellicotti infections in Missouri. If I am suspicious of this diagnosis in one of my patients, how can I test for it?

  • Diagnostic dilemma 

    Balla, Sudharshan (University of Missouri, Department of Medicine, Division of Hospital Medicine, 2013-07)
    Questions: 1) A 37 year old female is admitted with increasing dyspnea and orthopnea of 1 week duration. 2) A 68 year old male with history of hypertension was admitted with a blood pressure of 220/120 mm/Hg.

  • Monitoring and metabolic risks with second generation antipsychotics 

    Reiss, Rebecca (University of Missouri, Department of Medicine, Division of Hospital Medicine, 2013-07)
    As the armamentarium of antipsychotic medications continues to grow, so does data supporting expansion of their use for conditions beyond schizophrenia. For this reason, providers other than psychiatrists may see increasing ...